Drug Manufacturers - Specialty & Generic
Compare Stocks
5 / 10Stock Comparison
CPHI vs SGBX vs BLDR vs CHNR vs SOS
Revenue, margins, valuation, and 5-year total return — side by side.
Manufacturing - Metal Fabrication
Construction
Waste Management
Software - Infrastructure
CPHI vs SGBX vs BLDR vs CHNR vs SOS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Manufacturing - Metal Fabrication | Construction | Waste Management | Software - Infrastructure |
| Market Cap | $9M | $33K | $8.56B | $42M | $3M |
| Revenue (TTM) | $4M | $3M | $14.82B | $0.00 | $346M |
| Net Income (TTM) | $-3M | $-19M | $292M | $-14M | $-24M |
| Gross Margin | -8.4% | -87.3% | 29.9% | — | 3.7% |
| Operating Margin | -79.8% | -375.8% | 4.2% | — | -9.5% |
| Forward P/E | — | — | 18.0x | — | — |
| Total Debt | $4M | $7M | $5.65B | $0.00 | $0.00 |
| Cash & Equiv. | $627K | $376K | $182M | $3M | $237M |
CPHI vs SGBX vs BLDR vs CHNR vs SOS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| China Pharma Holdin… (CPHI) | 100 | 0.2 | -99.8% |
| Safe & Green Holdin… (SGBX) | 100 | 0.1 | -99.9% |
| Builders FirstSourc… (BLDR) | 100 | 371.9 | +271.9% |
| China Natural Resou… (CHNR) | 100 | 13.3 | -86.7% |
| SOS Limited (SOS) | 100 | 0.1 | -99.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CPHI vs SGBX vs BLDR vs CHNR vs SOS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CPHI is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.19, Low D/E 46.3%, current ratio 0.65x
SGBX carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 1 yrs, beta 0.15, yield 100.0%
- Beta 0.15, yield 100.0%, current ratio 0.08x
- Beta 0.15 vs SOS's 1.99
- 100.0% yield; 1-year raise streak; the other 4 pay no meaningful dividend
BLDR is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 6.0% 10Y total return vs CHNR's -93.5%
- 2.0% margin vs SGBX's -5.7%
- 2.6% ROA vs SGBX's -35.6%, ROIC 6.4% vs -625.7%
CHNR ranks third and is worth considering specifically for momentum.
- +2.1% vs SGBX's -97.3%
SOS is the clearest fit if your priority is growth exposure.
- Rev growth 150.4%, EPS growth -82.3%, 3Y rev CAGR -7.3%
- 150.4% revenue growth vs CHNR's -100.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 150.4% revenue growth vs CHNR's -100.0% | |
| Quality / Margins | 2.0% margin vs SGBX's -5.7% | |
| Stability / Safety | Beta 0.15 vs SOS's 1.99 | |
| Dividends | 100.0% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +2.1% vs SGBX's -97.3% | |
| Efficiency (ROA) | 2.6% ROA vs SGBX's -35.6%, ROIC 6.4% vs -625.7% |
CPHI vs SGBX vs BLDR vs CHNR vs SOS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CPHI vs SGBX vs BLDR vs CHNR vs SOS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BLDR leads in 4 of 6 categories
CPHI leads 0 • SGBX leads 0 • CHNR leads 0 • SOS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BLDR leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLDR and CHNR operate at a comparable scale, with $14.8B and $0 in trailing revenue. BLDR is the more profitable business, keeping 2.0% of every revenue dollar as net income compared to SGBX's -5.7%. On growth, SOS holds the edge at +48.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4M | $3M | $14.8B | $0 | $346M |
| EBITDAEarnings before interest/tax | -$2M | -$12M | $1.2B | -$12M | -$15M |
| Net IncomeAfter-tax profit | -$3M | -$19M | $292M | -$14M | -$24M |
| Free Cash FlowCash after capex | -$129,606 | -$5M | $862M | -$6M | -$141.0B |
| Gross MarginGross profit ÷ Revenue | -8.4% | -87.3% | +29.9% | — | +3.7% |
| Operating MarginEBIT ÷ Revenue | -79.8% | -3.8% | +4.2% | — | -9.5% |
| Net MarginNet income ÷ Revenue | -78.7% | -5.7% | +2.0% | — | -7.0% |
| FCF MarginFCF ÷ Revenue | -3.2% | -155.0% | +5.8% | — | -407.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -31.3% | -40.0% | -10.1% | — | +48.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +26.1% | +88.9% | -151.2% | +91.3% | +33.3% |
Valuation Metrics
Evenly matched — SGBX and CHNR and SOS each lead in 1 of 3 comparable metrics.
Valuation Metrics
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $9M | $32,963 | $8.6B | $42M | $3M |
| Enterprise ValueMkt cap + debt − cash | $12M | $7M | $14.0B | $41M | -$234M |
| Trailing P/EPrice ÷ TTM EPS | -1.93x | -0.00x | 19.90x | -88.65x | -0.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 18.03x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.52x | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 10.18x | — | — |
| Price / SalesMarket cap ÷ Revenue | 2.01x | 0.01x | 0.56x | — | 0.01x |
| Price / BookPrice ÷ Book value/share | 1.17x | — | 1.99x | 3.21x | 0.01x |
| Price / FCFMarket cap ÷ FCF | — | — | 10.03x | — | — |
Profitability & Efficiency
BLDR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BLDR delivers a 6.9% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-77 for SGBX. CPHI carries lower financial leverage with a 0.46x debt-to-equity ratio, signaling a more conservative balance sheet compared to BLDR's 1.30x. On the Piotroski fundamental quality scale (0–9), BLDR scores 5/9 vs CHNR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -37.6% | -77.2% | +6.9% | -15.7% | -5.6% |
| ROA (TTM)Return on assets | -20.0% | -35.6% | +2.6% | -5.3% | -4.9% |
| ROICReturn on invested capital | -32.2% | -625.7% | +6.4% | -0.0% | -9.5% |
| ROCEReturn on capital employed | -47.0% | — | +8.5% | -0.0% | -5.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 2 | 5 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.46x | — | 1.30x | — | — |
| Net DebtTotal debt minus cash | $3M | $7M | $5.5B | -$3M | -$237M |
| Cash & Equiv.Liquid assets | $626,879 | $375,873 | $182M | $3M | $237M |
| Total DebtShort + long-term debt | $4M | $7M | $5.6B | $0 | $0 |
| Interest CoverageEBIT ÷ Interest expense | -28.22x | -13.81x | 2.19x | -263.29x | — |
Total Returns (Dividends Reinvested)
BLDR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BLDR five years ago would be worth $14,799 today (with dividends reinvested), compared to $4 for SOS. Over the past 12 months, CHNR leads with a +2.1% total return vs SGBX's -97.3%. The 3-year compound annual growth rate (CAGR) favors BLDR at -12.0% vs SGBX's -87.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -57.0% | -52.9% | -26.0% | +22.2% | -24.0% |
| 1-Year ReturnPast 12 months | -73.8% | -97.3% | -30.3% | +2.1% | -75.3% |
| 3-Year ReturnCumulative with dividends | -97.2% | -99.8% | -31.9% | -79.7% | -98.3% |
| 5-Year ReturnCumulative with dividends | -99.8% | -99.9% | +48.0% | -92.6% | -100.0% |
| 10-Year ReturnCumulative with dividends | -99.5% | -100.0% | +596.0% | -93.5% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -69.6% | -87.5% | -12.0% | -41.2% | -74.3% |
Risk & Volatility
Evenly matched — SGBX and CHNR each lead in 1 of 2 comparable metrics.
Risk & Volatility
SGBX is the less volatile stock with a 0.15 beta — it tends to amplify market swings less than SOS's 1.99 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHNR currently trades 52.4% from its 52-week high vs SGBX's 1.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.19x | 0.15x | 1.66x | 1.10x | 1.99x |
| 52-Week HighHighest price in past year | $2.60 | $96.00 | $151.03 | $8.20 | $9.62 |
| 52-Week LowLowest price in past year | $0.50 | $0.79 | $73.40 | $3.16 | $0.90 |
| % of 52W HighCurrent price vs 52-week peak | +20.0% | +1.0% | +51.2% | +52.4% | +11.9% |
| RSI (14)Momentum oscillator 0–100 | 34.9 | 35.2 | 42.0 | 55.8 | 46.7 |
| Avg Volume (50D)Average daily shares traded | 26K | 652K | 2.4M | 893K | 117K |
Analyst Outlook
BLDR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
SGBX is the only dividend payer here at 100.00% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — | — |
| Price TargetConsensus 12-month target | — | — | $106.64 | — | — |
| # AnalystsCovering analysts | — | — | 43 | — | — |
| Dividend YieldAnnual dividend ÷ price | — | +100.0% | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | 2 | 0 | — |
| Dividend / ShareAnnual DPS | — | $13.85 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +4.8% | 0.0% | 0.0% |
BLDR leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
CPHI vs SGBX vs BLDR vs CHNR vs SOS: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is CPHI or SGBX or BLDR or CHNR or SOS a better buy right now?
For growth investors, SOS Limited (SOS) is the stronger pick with 150.
4% revenue growth year-over-year, versus -69. 9% for Safe & Green Holdings Corp. (SGBX). Builders FirstSource, Inc. (BLDR) offers the better valuation at 19. 9x trailing P/E (18. 0x forward), making it the more compelling value choice. Analysts rate Builders FirstSource, Inc. (BLDR) a "Buy" — based on 43 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CPHI or SGBX or BLDR or CHNR or SOS?
Over the past 5 years, Builders FirstSource, Inc.
(BLDR) delivered a total return of +48. 0%, compared to -100. 0% for SOS Limited (SOS). Over 10 years, the gap is even starker: BLDR returned +596. 0% versus SGBX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CPHI or SGBX or BLDR or CHNR or SOS?
By beta (market sensitivity over 5 years), Safe & Green Holdings Corp.
(SGBX) is the lower-risk stock at 0. 15β versus SOS Limited's 1. 99β — meaning SOS is approximately 1268% more volatile than SGBX relative to the S&P 500. On balance sheet safety, China Pharma Holdings, Inc. (CPHI) carries a lower debt/equity ratio of 46% versus 130% for Builders FirstSource, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — CPHI or SGBX or BLDR or CHNR or SOS?
By revenue growth (latest reported year), SOS Limited (SOS) is pulling ahead at 150.
4% versus -69. 9% for Safe & Green Holdings Corp. (SGBX). On earnings-per-share growth, the picture is similar: China Natural Resources, Inc. grew EPS 95. 9% year-over-year, compared to -82. 3% for SOS Limited. Over a 3-year CAGR, SOS leads at -7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CPHI or SGBX or BLDR or CHNR or SOS?
Builders FirstSource, Inc.
(BLDR) is the more profitable company, earning 2. 9% net margin versus -341. 2% for Safe & Green Holdings Corp. — meaning it keeps 2. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BLDR leads at 5. 2% versus -195. 0% for SGBX. At the gross margin level — before operating expenses — BLDR leads at 29. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CPHI or SGBX or BLDR or CHNR or SOS?
In this comparison, SGBX (100.
0% yield) pays a dividend. CPHI, BLDR, CHNR, SOS do not pay a meaningful dividend and should not be held primarily for income.
07Is CPHI or SGBX or BLDR or CHNR or SOS better for a retirement portfolio?
For long-horizon retirement investors, Safe & Green Holdings Corp.
(SGBX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 15), 100. 0% yield). SOS Limited (SOS) carries a higher beta of 1. 99 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SGBX: -100. 0%, SOS: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CPHI and SGBX and BLDR and CHNR and SOS?
These companies operate in different sectors (CPHI (Healthcare) and SGBX (Industrials) and BLDR (Industrials) and CHNR (Industrials) and SOS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CPHI is a small-cap quality compounder stock; SGBX is a small-cap income-oriented stock; BLDR is a small-cap quality compounder stock; CHNR is a small-cap quality compounder stock; SOS is a small-cap high-growth stock. SGBX pays a dividend while CPHI, BLDR, CHNR, SOS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.